JPS5626876A - 44phenoxypiperidine* its manufacture and drug containing it - Google Patents

44phenoxypiperidine* its manufacture and drug containing it

Info

Publication number
JPS5626876A
JPS5626876A JP10523180A JP10523180A JPS5626876A JP S5626876 A JPS5626876 A JP S5626876A JP 10523180 A JP10523180 A JP 10523180A JP 10523180 A JP10523180 A JP 10523180A JP S5626876 A JPS5626876 A JP S5626876A
Authority
JP
Japan
Prior art keywords
group
carbon atoms
denotes
hydrogen atom
new compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10523180A
Other languages
English (en)
Inventor
Aisutetsuteru Kurausu
Peeteru Kurai Hansu
Giyunteru Menge Haintsu
Shieefueru Harutoman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIIKU GURUDEN RONBERUGU CHEM F
Original Assignee
BIIKU GURUDEN RONBERUGU CHEM F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIIKU GURUDEN RONBERUGU CHEM F filed Critical BIIKU GURUDEN RONBERUGU CHEM F
Publication of JPS5626876A publication Critical patent/JPS5626876A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/94—Oxygen atom, e.g. piperidine N-oxide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
JP10523180A 1979-08-03 1980-08-01 44phenoxypiperidine* its manufacture and drug containing it Pending JPS5626876A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH712779 1979-08-03

Publications (1)

Publication Number Publication Date
JPS5626876A true JPS5626876A (en) 1981-03-16

Family

ID=4320395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10523180A Pending JPS5626876A (en) 1979-08-03 1980-08-01 44phenoxypiperidine* its manufacture and drug containing it

Country Status (15)

Country Link
US (1) US4333942A (ja)
EP (1) EP0023706B1 (ja)
JP (1) JPS5626876A (ja)
AT (1) ATE2670T1 (ja)
AU (1) AU534786B2 (ja)
CA (1) CA1147733A (ja)
DE (1) DE3062207D1 (ja)
DK (1) DK334480A (ja)
ES (1) ES8104991A1 (ja)
GR (1) GR69902B (ja)
IE (1) IE50079B1 (ja)
IL (1) IL60715A (ja)
NZ (1) NZ194528A (ja)
PT (1) PT71644B (ja)
ZA (1) ZA804696B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910351A (en) * 1987-03-16 1990-03-20 E. I. Du Pont De Nemours And Company Process for preparing (polyfluoroalkyl)polyfluoroarenes

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914204A (en) * 1988-03-14 1990-04-03 Hoechst-Roussel Pharmaceuticals Incorporated 4-Pentafluorophenoxypiperidines
US4853384A (en) * 1988-03-14 1989-08-01 Hoechst-Roussel Pharmaceuticals Inc. 1-carbonyl derivatives of 4-aryl-4-aryloxypiperidines
US4954511A (en) * 1988-03-14 1990-09-04 Hoechst-Roussell Pharmaceuticals Inc. 4-pentafluorophenoxypiperidines
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
SE9904723D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
US7851629B2 (en) * 2004-06-08 2010-12-14 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
MXPA06013941A (es) * 2004-06-08 2007-12-10 Neurosearch Sweden Ab Fenilpiperidinas disustituidas, novedosas, como moduladores de la neurotransmision de dopamina y serotonina.
SE0401465D0 (sv) * 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
MX2007004216A (es) * 2004-10-13 2007-10-10 Neurosearch Sweden Ab Proceso para la sintesis de 4-(3-sulfonil)-piperidinas.
AU2005293754B2 (en) * 2004-10-13 2011-07-21 Teva Pharmaceuticals International Gmbh Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-N-propyl-piperidine
ITTO20050234A1 (it) * 2005-04-08 2006-10-09 Univ Pisa Derivati 4-arilpiperidinici e loro uso per la preparazione di un medicamento per il trattamento di disordini del snc
SE529246C2 (sv) * 2005-10-13 2007-06-12 Neurosearch Sweden Ab Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
EP2787997A4 (en) 2011-12-08 2015-05-27 Ivax Int Gmbh HYDROBROMIDE SALT OF PRIDOPIDINE
JP6177875B2 (ja) 2012-04-04 2017-08-09 テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーＴｅｖａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ 併用療法のための医薬組成物
AU2014346483B2 (en) 2013-11-07 2019-01-17 The University Of Kansas Biphenylamide derivative Hsp90 inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895309A (en) * 1959-11-18 1962-05-02 Res Lab Dr C Janssen Nv Pyrrolidine and piperidine derivatives
BE615349A (nl) 1961-03-22 1962-09-20 Res Lab Dr C Janssen Nv N-arylalkyl- en N-arylalkenylderivaten van 4-alkoxy-4-fenylpiperidinen.
FR1799M (fr) * 1961-03-22 1963-04-29 Res Lab Nv Dérivés des 4-alcoxy-4-phénylpipéridines a substituants alcoyles supérieurs sur l'azote.
US3260723A (en) * 1963-08-27 1966-07-12 Parke Davis & Co 4-phenoxy piperidines; alpha4-phenoxy piperideines
US3551433A (en) * 1967-06-21 1970-12-29 Us Army Preparation of 4-phenyl-4-acyloxypiperidine
US3506671A (en) * 1967-11-01 1970-04-14 Smithkline Corp 1-naphthylalkyl-4-phenylpiperidine derivatives
SE7708555L (sv) * 1976-08-05 1978-02-06 Delmar Chem 4-arylpiperidinderivat och forfarande for framstellning derav
US4116963A (en) 1977-05-23 1978-09-26 G.D. Searle & Co. 3,3,3-triarylalkyl-4-phenylalkyl-4-hydroxy piperidines and related compounds
US4216218A (en) * 1979-02-23 1980-08-05 American Hoechst Corporation Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910351A (en) * 1987-03-16 1990-03-20 E. I. Du Pont De Nemours And Company Process for preparing (polyfluoroalkyl)polyfluoroarenes

Also Published As

Publication number Publication date
PT71644A (de) 1980-09-01
DE3062207D1 (en) 1983-04-07
GR69902B (ja) 1982-07-20
DK334480A (da) 1981-02-04
AU534786B2 (en) 1984-02-16
CA1147733A (en) 1983-06-07
IE801615L (en) 1981-02-03
IL60715A0 (en) 1980-09-16
ES493922A0 (es) 1981-06-01
EP0023706A1 (de) 1981-02-11
IL60715A (en) 1983-12-30
EP0023706B1 (de) 1983-03-02
ZA804696B (en) 1981-08-26
NZ194528A (en) 1982-05-25
ES8104991A1 (es) 1981-06-01
IE50079B1 (en) 1986-02-05
ATE2670T1 (de) 1986-03-15
US4333942A (en) 1982-06-08
AU6101580A (en) 1981-02-05
PT71644B (de) 1982-01-21

Similar Documents

Publication Publication Date Title
JPS5626876A (en) 44phenoxypiperidine* its manufacture and drug containing it
MY102866A (en) Amide derivatives.
AU637695B2 (en) Therapeutic agents
EG16546A (en) Therapeutic agents
ATE44142T1 (de) Isoxazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ES487631A1 (es) Procedimiento para la obtencion de hexahidro-1,4-oxazepinas
ES8702392A1 (es) Un procedimiento para preparar compuestos heterociclicos, en particular compuestos con un anillo de tiadiazinona
HU894471D0 (en) Process for the preparation of 15-amino-20,21-dinor-eburnamenine derivatives and pharmaceutical compositions containing them